Effect of concomitant administration of cyclosporine and ketoconazole in children with focal segmental glomerulosclerosis

American Journal of Nephrology

Volumn 24, Issue 3, 2004, Pages 301-306

  El Husseini, Amr ^a   El Basuony, Fathy ^a   Mahmoud, Ihab ^a   Donia, Ahmed ^a   Hassan, Nabil ^a   Sayed Ahmed, Nagy ^a   Sobh, Mohamed ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Cyclosporine; Focal segmental glomerulonephritis; Ketoconazole; Nephrotic syndrome

Indexed keywords

CYCLOSPORIN A; KETOCONAZOLE; STEROID;

AGE DISTRIBUTION; ARTICLE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG COST; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG SAFETY; FEMALE; FOCAL GLOMERULONEPHRITIS; GINGIVA HYPERPLASIA; GRAFT REJECTION; HIRSUTISM; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX RATIO;

CHILD; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KETOCONAZOLE; MALE; RETROSPECTIVE STUDIES;

EID: 4043101108     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078395     Document Type: Article

References (26)

1. Niaudet P, Habib R: Cyclosporine in the treatment of idiopathic nephrosis (review 71 refs). J Am Soc Nephrol 1994;5:1049-1056.
2. Chishti AS, Sorof JM, Brewer ED, Kale AS: Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose. Am J Kidney Dis. 2001;38:754-760.
3. Smith SL, Hampton EM, Pederson JA: Clinical and medicoeconomic impact of the cyclosporine-diltiazem interaction in renal transplant recipients. Pharmacotherapy 1994;14:471-476.
4. Keogh A, Spratt P, McCosker C, Macdonald P, Mundy J, Kaan A: Ketoconazole to reduce the need for cyclosporine after cardiac transplantation. N Engl J Med 1995;333:628-633.
5. Sobh M, El-Agroudy A, Mostafa F, Harras F, El-Bedewy M, Ghoneim M: Co-administration of ketoconazole to cyclosporine treated kidney transplant recipients: A prospective randomized study. Am J Nephrol 1995;15:493-499.
6. Jones TE: The use of other drugs to allow a lower dosage of cyclosporine to be used: Therapeutic and pharmacoeconomic considerations. Clin Pharmacokinet 1997;32:357-67.
7. Sobh MA, Hamdy AF, El Agroudy AE, El Sayed K, El-Diasty T, Bakr MA, Ghoneim MA: Co-administration of ketoconazole and cyclosporine for kidney transplant recipients: longterm follow-up and study of metabolic consequences. Am J Kidney Dis 2001;37:510-517.
8. Meyrier A, Niaudet P, Brodehl J: Optimal use of Sandimmun in Nephrotic Syndrome. Berlin, Springer, 1992, P1.
9. Everitt BS: Statistical Methods for Medical Investigators, ed 2. New York, Wiley, 1994.
10. Takeda A, Takimoto H, Mizusawa Y , Simoda M: Prediction of subsequent relapse in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 2001;16:888-893.
11. Klinika B, Kaczmarczyk I, Radziszewski A, Sulowicz W: Use of cyclosporine A and new immunosuppressive drugs in the therapy of glomerulonephritis. Przegl Lek 2001;58:798-804.
12. Barclay PG, Allen RDM, Stewart JH, Ng K, Chapman JR: Costs of immunosuppressive therapies used in renal transplantation. Transplant Proc 1992;24:165-166.
13. First MR , Schroeder TJ, Michela A, Hariharan S, Weiskittel P, Alexander JW: Cyclosporine-ketoconazole interaction: Long-term follow-up and preliminary results of a randomized trial. Transplantation 1993;55:1000-1004.
14. Buttman SM, Wild JC,Nolan PE, Fagan TC, Filney PR, Hick MJ, Capeland TG: Prospective study of safety and financial benefit of ketoconazole as adjuvant therapy to cyclosporine after heart transplantation. J Heart Lung Transplant 1991;10:351-358.
15. Glynn AM, Slaughter RL, Brass C, D'Ambrosio R, Jusko WJ: Effects of ketoconazole on methylprednisolone pharmacokinetics and cortisol secretion. Clin Pharmacol Ther 1986;39:654-659.
16. Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL: A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int 1999;56:2220-2226.
17. Gregory MJ, Smoyer WE, Sedman A, Kershaw DB, Valentini RP, Johnson K, Bunchman TE: Long-term cyclosporine therapy for pediatric nephrotic syndrome: A clinical and histologic analysis. J Am Soc Nephrol 1996;7:543-549.
18. Lieberman KV, Tejani A: A randomized double-blind placebo-controlled trial of cyclosporine in steroid resistant idiopathic focal segmental glomerulosclerosis in children. J Am Soc Nephrol 1996;7:56-63.
19. Ingulli E, Singh A, Baqi N, Ahmad H, Moazami S, Tejani A: Aggressive, long-term cyclosporine therapy for steroid resistant focal segmental glomerulosclerosis. J Am Soc Nephrol 1995;5:1820-1825.
20. Melocton TL, Kamil ES, Cohen AH, Fine RN: Long-term cyclosporine A treatment of steroid-resistant and steroid-dependent nephrotic syndrome. Am J Kidney Dis 1991;18:583-588.
21. Senior DS, Show JT: In vitro effect of fluconazole and ketoconazole on mouth lymphocyte proliferation and on Canadian blastospore destruction by human polymorphonuclear leucocytes. Int J Immunol Pharmacol 1988;10:169-176.
22. First MR, Schroeder TJ, Alexander JW, Stephens GW, Weiskittel P, Pesce AJ: Cyclosporine dose reduction by ketoconazole administration in renal transplant recipients. Transplantation 1991;51:365-370.
23. Rosano TG, Pell MA, Freed BM, Lampert N: Cyclosporine and metabolites in blood from renal allograft recipients with nephrotoxicity, rejection, or good renal function: Comparative radioimmunoassay studies. Transplant Proc 1988;20(suppl 2):S330-S338.
24. Usta M, Ersoy A, Dilek K, Ozdemir B, Yavuz M, Gullulu M, Yurtkuran M: Efficacy of losartan in patients with primary focal segmental glomerulosclerosis resistant to immunosuppressive treatment. J Intern Med 2003;253:329-334.
25. Lorber MI, Van Buren CT and Flechner SM: Hepatobiliary and pancreatic complications of cyclosporine therapy in 1,466 transplant recipients. Transplantation 1987;43:35-40.
26. Bethesda Md: Ketoconazole; in McEvoy GK (ed): AHFS Drug Information. Washington, American Society of Hospital Pharmacists, 1991, chap 91, pp 82-86.